ATRA - Atara Biotherapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ATRA is currently covered by 2 analysts with an average price target of $15.5. This is a potential upside of $13.42 (76.74%) from yesterday's end of day stock price of $8.77.

Atara Biotherapeutics's activity chart (see below) currently has 25 price targets and 37 ratings on display. The stock rating distribution of ATRA is 75% BUY and 25% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 62.61% with an average time for these price targets to be met of 268.26 days.

Highest price target for ATRA is $18, Lowest price target is $13, average price target is $15.5.

Most recent stock forecast was given by JOHN NEWMAN from CANACCORD on 08-May-2026. First documented stock forecast 03-Dec-2015.

Currently out of the existing stock ratings of ATRA, 3 are a BUY (75%), 1 are a HOLD (25%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 08-May-2026

$13

$4.62 (55.13%)

$6

2 months 27 days ago
(08-May-2026)

5/7 (71.43%)

$4.66 (55.88%)

542

Buy Since 18-Aug-2025

$18

$9.62 (114.80%)

$16

8 months 14 days ago
(21-Nov-2025)

4/6 (66.67%)

$4.32 (31.58%)

167

Hold Since 22-May-2024

1 years 6 months 8 days ago
(28-Jan-2025)

2/4 (50%)

$129.5 (20.06%)

149

Hold Since 02-Nov-2023

$5

$-3.38 (-40.33%)

$10

1 years 6 months 14 days ago
(21-Jan-2025)

3/5 (60%)

$-1.05 (-17.36%)

310

Buy Since 04-Jan-2021

$25

$16.62 (198.33%)

1 years 7 months 15 days ago
(20-Dec-2024)

0/2 (0%)

$13.6 (119.30%)

Show more analysts

Please expand the browser size to see the chart

What is ATRA (Atara Biotherapeutics) average time for price targets to be met?

On average it took 268.26 days on average for the stock forecasts to be realized with a an average price target met ratio 62.61

Which analyst has the current highest performing score on ATRA (Atara Biotherapeutics) with a proven track record?

ROBERT BURNS

Which analyst has the most public recommendations on ATRA (Atara Biotherapeutics)?

Robert Burns works at HC WAINWRIGHT and has 33 price targets and 23 ratings on ATRA

Which analyst is the currently most bullish on ATRA (Atara Biotherapeutics)?

Maury Raycroft with highest potential upside - $620.35

Which analyst is the currently most reserved on ATRA (Atara Biotherapeutics)?

Benjamin Burnett with lowest potential downside - -$5.51

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?